Bayer and Aignostics to collaborate on next generation precision oncology

Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development

CuraTeQ Biologics announces the successful Phase 1 clinical study outcome of their BP11 product

Successful use of Zidebactam/Cefepime to treat skull bone infection & pneumonia caused by extreme-drug resistant pseudomonas

With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained

Govt supports Alchem Synthon with Rs. 8.6 crore loan assistance for chemical production facility

The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities

Strides receives USFDA approval for Gabapentin Tablets

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty

Bayer strengthens pharma portfolio with new cardiology drug acoramidis

Acquisition of exclusive commercialization rights for European markets

Dr Mandaviya launches AYUSH-ICMR Advanced Centre for Integrated Health Research in AIIMS

Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research

Health Minister Mandaviya inaugurates 27 greenfield bulk drug park, 13 medical device manufacturing plants

PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30

Biocon Biologics secures US market entry date for Bmab 1200

The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA

Ministry of Ayush signed MoU with Research and Information System for Developing Countries

Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon